PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Chemical Engineering-Pharmaceutical Engineering, University of Tehran, Tehran, Iran.\', \'Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jcph.1874
?:hasPublicationType
?:journal
  • Journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33870531
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.997
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Baricitinib: From Rheumatoid Arthritis to COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33870531>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33870531>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all